Price: $180.14
· 1 day: -0.01% · 5 days: -0.61% · 1 month: +5.15% · YTD: +26.41%
As of 2026-11-12 21:00 UTC.
52-week range: $125.34 – $189.25 (currently at 86% of the range).
LYV is in an uptrend, momentum firm. $188.26 is the level overhead; $175.16 the first support below.
5 of 6 technical checks lean bullish.
| Trend | Uptrend · above 50-day & 200-day |
|---|---|
| Momentum | RSI 59.0 · MACD bullish |
| Trend strength | ADX 11.0 · weak or range |
| Location | +4.3% vs 50-day MA |
| 52-week range | -4% from high · +43% from low |
| Volatility | ATR 5.35 · ~3.0%/day |
| Level | Type | Distance |
|---|---|---|
| $188.26 (resistance) | swing zone | 4.51% |
| $200.0 (resistance) | round | 11.02% |
| $225.0 (resistance) | round | 24.9% |
| $175.16 (support) | swing zone | -2.76% |
| $172.74 (support) | sma 50 | -4.11% |
| $171.81 (support) | swing zone | -4.62% |
| RSI (14) | 59.01 | MACD | 1.9034 |
|---|---|---|---|
| ADX (14) | 11.0 | ATR (14) | 5.35 |
| 50-day average | $172.74 | 200-day average | $168.22 |
Next earnings: 2026-11-05. LYV earnings date, time and past reactions.
Report of 2026-11-03.
Live Nation Entertainment (LYV) closed at $178.55 on November 3, 2026, its highest close of the recent run and two days before earnings. The shares are up 3.9% over five days while the S&P 500 fell 2.1%. The balance of evidence leans positive for the next two to six weeks, with medium conviction, because the daily and weekly trends agree and the stock is outpacing the market. The upside math from the nearest breakout level is thinner than the trend suggests.
The main news item is legal. In a court filing, LYV disclosed that President Donald Trump attended the White House meeting where the terms of a settlement with the Justice Department's antitrust case were finalized, Bloomberg reported on October 23, 2026. The article gives few details on the terms. What it does show is that the biggest overhang on the stock, the antitrust case, is being resolved by negotiation rather than by a verdict. That matters more than any product headline in the period. The other items in the news flow, such as ticketing NFT features and unrelated earnings transcripts, do not bear on the price.
The stock's reaction is clearer than its cause. LYV has gained 5.9% over the past month while the S&P 500 lost 2.1%, and it is up 25.4% year to date against 10.5% for the index. Over the last five days the market fell 2.1% and LYV rose 3.9%, so the move did not come from the market tide. No sector fund is available in the data, so the sector's share cannot be separated out. No single headline in the last five days explains the gain, and it would be wrong to pin it on one. Today's volume was 37.3% above its 20-day average, which says real money is participating in the advance. Part of the strength looks like positioning ahead of the report, but that is an inference, not something the data shows.
The argument about LYV is mostly about litigation and what it costs. The bullish case, made in Seeking Alpha, is that the stock had slipped about 6% since a July 1 Buy rating. The author sees an entry point for risk-tolerant investors, calls the valuation in line with peers, and expects strong quarterly results. The same piece names antitrust litigation as the main risk, and that is where the skeptics sit. Settlement terms are not yet public in detail, and a settlement can still draw objections or be changed. The stock has already moved well above the level the article was written at, so some of that argument has been paid out.
Analysts are positive but not stretched. Of 24 covering the stock, the consensus is buy, with a mean price target of $202.63 and a range from $145 to $222. The shares sit 11.9% below that mean, so the Street sees room, but the $145 low target shows a minority with a very different view. Market value is about $41.6 billion.
The long-term thesis is intact. The price is above its 40-week average, the 50-day average at $173.01 is above the 200-day at $166.98, and the stock is 42.2% above its 52-week low of $125.61. It is 5.3% below its 52-week high of $188.46. That is an established uptrend that has pulled back and recovered, and it is now working back toward the old high. The stock is leading the S&P 500 by 5.0% over 50 days and 3.5% over 200 days.
For the next two to six weeks the evidence leans positive, with medium conviction, 2 of 4 points. Two things support it: the daily trend runs with the weekly uptrend, and the stock has led the market over 50 days. Conviction stops there because the other two points are not in hand. The stock has not yet cleared the swing-zone resistance, and the earnings report is an unresolved event.
The strongest case against is the stretch. RSI is 73, which is overbought, and the shares have climbed into a report that can move them sharply either way. A stock that has outrun the market by this much can give some of it back on a merely adequate quarter. The legal outcome also remains open. These points do not outweigh the trend, which is intact and well supported by volume, but they are why conviction is medium and not higher.
The structure holds above $175.16, a swing zone, and the first crack comes on a break below it. The trend ends below $173.01, the 50-day average. The next supports are $171.81, $168.54 and the 200-day average at $166.98. These are the points where buyers have stepped in before, and the 50-day is the line the weekly trend is measured against.
The breakout level is a daily close above $188.35, the swing-zone resistance just under the 52-week high, on volume above its 20-day average. From there the math runs to $200 and then $225, both round numbers. The stop would sit at $174.15, which is $175.16 minus a quarter of the 14-day ATR. The reward-to-risk is 0.8 to 1 to $200 and 2.6 to 1 to $225. That does not reach the 3 to 1 that makes a breakout worth the risk. It would take a target beyond $225, or an entry closer to the stop, to change that. Note that $225 is already above the highest analyst target of $222.
A weekly close below $173.01, the 50-day average, would change the picture, because it would break the line the weekly uptrend rests on. The non-price fact that could do it is the antitrust settlement coming apart, for example if its terms are rejected or reopened, or if earnings show that the legal outcome costs more in operations than expected. Either would put back the overhang the stock has recently shed.
Interactive LYV chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs